Side-by-side financials for FDMT and BNTX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | FDMT | BNTX |
|---|---|---|
| Market cap | - | $22.64 B |
| US-listed rank | - | #570 |
| Revenue (latest FY) | $85.21M | - |
| Net income (latest FY) | -$140.11M | - |
| Net margin | -164.4% | - |
| SEC filings | 397 | 548 |
Full pages: 4D Molecular Therapeutics, Inc. and BioNTech SE, or browse the full rankings.